Patients Discontinuing Weight-Loss Jabs Gain Back Pounds Four Times Faster Compared to Dieters

Fresh analysis indicates that patients who discontinue popular GLP-1 drugs like Mounjaro or Wegovy may regain reduced body mass far faster than those who halt traditional diet and exercise regimens.

Findings released in a leading medical journal shows that while overweight people frequently drop substantial amounts of their body weight while using the jabs, the weight comes back at an estimated rate of nearly a kilo each month after stopping.

"Users buying such treatments should be aware of the danger of rapid weight regain when the therapy ends," warns lead investigator Dr. Susan Jebb.

Such speed of recovery means a reversion to pre-treatment mass in about 18 months.

Analyzing Therapies

The analysis, which looked at dozens of studies involving thousands of patients, contrasted the results of these new drugs with older methods.

The team note that people who lose weight through diet and exercise usually see a slower creep back—perhaps 0.1 kg a month—after stopping.

Explaining the Rapid Rebound

Experts propose the mode of action of the drugs is key to understanding the amplified weight return.

GLP-1 drugs copy a natural hormone called GLP-1, which controls hunger.

"Sustained high doses of the hormone concentrations several times higher than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also lessen responsiveness to its actions," noted Dr. Adam Collins, a dietetics expert.

"Withdrawal of this hormone supplement leads to hunger is uncontrolled, making excessive eating far more likely."

A Lifelong Condition?

Medical guidelines advise the injections for individuals with weight-linked health risks, alongside recommended lifestyle changes.

Professionals contend that, considering the high risk of relapse, the therapy might need to be life-long.

This perspective is echoed by drug manufacturers, who state that the results "underscore the long-term nature of obesity," similar to managing conditions like hypertension.

Patient Testimonies

People who have come off the jabs describe a sudden return of appetite.

"I experienced a trigger that goes on and I was suddenly extremely hungry," described one woman.

The struggle is exacerbated if individuals have not established permanent lifestyle or habit modifications during treatment.

Significant Interest

Figures indicate that millions of people in the UK have tried these injections in the last 12 months, with desire being substantial.

• Use is higher among women compared to males.
• The middle-aged age group shows the greatest usage rates.
• Many access the medications through private healthcare rather than public health services.

In conclusion, researchers caution that while the jabs are powerful agents for weight loss, they are not a permanent fix and lasting health benefits relies on ongoing behavioural support.